Functional Distinction between the Full-Length Human Androgen Receptor and Its Splicing Variants in Castration-Resistant Prostate Cancer

被引:0
|
作者
Hu, R.
Lu, C.
De Marzo, A. M.
Isaacs, W. B.
Luo, J.
机构
[1] Univ Wisconsin, Madison, WI USA
[2] Johns Hopkins Univ, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
891
引用
收藏
页码:214A / 214A
页数:1
相关论文
共 50 条
  • [31] Functional interplay between the prototype human androgen receptor and its splicing variants that signify hormone refractory prostate cancer
    Hu, Rong
    Wei, Shuanzeng
    Isaacs, William
    Bova, G. Steven
    Luo, Jun
    CANCER RESEARCH, 2009, 69
  • [32] Androgen biosynthesis in castration-resistant prostate cancer
    Penning, Trevor M.
    ENDOCRINE-RELATED CANCER, 2014, 21 (04) : T67 - T78
  • [33] Targeting persistent androgen receptor signaling in castration-resistant prostate cancer
    Graham, Laura
    Schweizer, Michael T.
    MEDICAL ONCOLOGY, 2016, 33 (05)
  • [34] Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
    Perner, Sven
    Cronauer, Marcus V.
    Schrader, Andres Jan
    Klocker, Helmut
    Culig, Zoran
    Baniahmad, Aria
    ONCOTARGET, 2015, 6 (34) : 35542 - 35555
  • [35] Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer
    Won Kim
    Charles J Ryan
    Current Treatment Options in Oncology, 2012, 13 : 189 - 200
  • [36] Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
    George, Daniel J.
    Morgans, Alicia K.
    Constantinovici, Niculae
    Khan, Nasreen
    Khan, Javeed
    Chen, Guifang
    Hlebec, Vlasta
    Shore, Neal D.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [37] Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
    Conteduca, Vincenza
    Jayaram, Anuradha
    Romero-Laorden, Nuria
    Wetterskog, Daniel
    Salvi, Samanta
    Gurioli, Giorgia
    Scarpi, Emanuela
    Castro, Elena
    Marin-Aguilera, Mercedes
    Lolli, Cristian
    Schepisi, Giuseppe
    Maugeri, Antonio
    Wingate, Anna
    Farolfi, Alberto
    Casadio, Valentina
    Medina, Ana
    Puente, Javier
    Mendez Vidal, Ma Jose
    Morales-Barrera, Rafael
    Villa-Guzman, Jose C.
    Hernando, Susana
    Rodriguez-Vida, Alejo
    Gonzalez-del-Alba, Aranzazu
    Mellado, Begona
    Gonzalez-Billalabeitia, Enrique
    Olmos, David
    Attard, Gerhardt
    De Giorgi, Ugo
    EUROPEAN UROLOGY, 2019, 75 (03) : 368 - 373
  • [38] Spironolactone: A selective androgen receptor modulator in castration-resistant prostate cancer
    Barthelemy, Philippe
    Erdmann, Eva
    Duclos, Brigitte
    Bergerat, Jean Pierre
    Kurtz, Jean-Emmanuel
    Ceraline, Jocelyn
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [39] Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
    Scher, HI
    Buchanan, G
    Gerald, W
    Butler, LM
    Tilley, WD
    ENDOCRINE-RELATED CANCER, 2004, 11 (03) : 459 - 476
  • [40] Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
    Obinata, Daisuke
    Lawrence, Mitchell G.
    Takayama, Kenichi
    Choo, Nicholas
    Risbridger, Gail P.
    Takahashi, Satoru
    Inoue, Satoshi
    FRONTIERS IN ONCOLOGY, 2020, 10